Advanta VXT Vascular Graft, Flixene Vascular Graft

Advanta VXT Vascular Graft, Flixene Vascular Graft is an FDA 510(k)-cleared medical device (K231972) manufactured by Atrium Medical Corporation. This device is classified under the Cardiovascular specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on March 27, 2024. Regulation: 8.